Prognostic Surveillance

Prognostic Surveillance is a tumor surveillance framework that systematically monitors clinical and molecular indicators over time to stratify patients by predicted disease outcome, distinguishing itself through its focus on longitudinal assessment of biomarkers and risk factors to guide personalized intervention strategies.

78

Publications

4.7K

Citations

661

Authors

296

Institutions

Publications per year

2017–2026

37

Authors

661

  1. TP
    Tony Panzarella

    Princess Margaret Cancer Centre, Canada

    2 publications · 607 citations

    2

    h-index

  2. AC
    Antoni Castells

    Universitat de Barcelona, Spain

    2 publications · 406 citations

    2

    h-index

  3. LS
    Lena Specht

    Rigshospitalet, Denmark

    2 publications · 607 citations

    2

    h-index

  4. AJ
    Allan J. Pantuck

    University of California, Los Angeles, United States

    2 publications · 346 citations

    2

    h-index

  5. AS
    Arie S. Belldegrun

    University of California, Los Angeles, United States

    2 publications · 346 citations

    2

    h-index

1–5 of 661

Venues

  1. Cancer

    4 publications · 592 citations

    4

    h-index

  2. The Journal of Urology

    3 publications · 404 citations

    3

    h-index

  3. Journal of Clinical Oncology

    3 publications · 932 citations

    3

    h-index

  4. PubMed

    Repository · 3 publications · 138 citations

    3

    h-index

  5. Annals of Surgical Oncology

    3 publications · 111 citations

    3

    h-index

1–5